100928-04-9

Basic information

• Product Name: Toluene-4-sulfonic acid2-[4-(tert-butyl-dimethyl-silanyloxy)-7a-methyl-octahydro-inden-1-yl]-propyl ester
• Synonyms: Toluene-4-sulfonic acid2-[4-(tert-butyl-dimethyl-silanyloxy)-7a-methyl-octahydro-inden-1-yl]-propyl ester;1H-Indene-1-ethanol,4-[[(1,1-dimethylethyl)dimethylsilyl]oxy]octahydro-b,7a-dimethyl-, 1-(4-methylbenzenesulfonate), (bS,1R,3aR,4S,7aR)-;[(2S)-2-[(4S,7aR)-4-(tert-butyl(dimethyl)silyl)oxy-7a-methyl-1,2,3,3a,4,5,6,7-octahydroinden-1-yl]propyl] 4-methylbenzenesulfonate
• CAS NO: 100928-04-9
• Molecular Formula: C₂₆H₄₄O₄SSi
• Molecular Weight: 480.78
• Mol File: 100928-04-9.mol
• Article Data: 15

Chemical Properties

• Boiling Point: 521.6±23.0 °C(Predicted)
• Appearance: /
• Density: 1.07±0.1 g/cm3(Predicted)
• Refractive Index: 1.52
• CAS DataBase Reference: Toluene-4-sulfonic acid2-[4-(tert-butyl-dimethyl-silanyloxy)-7a-methyl-octahydro-inden-1-yl]-propyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Toluene-4-sulfonic acid2-[4-(tert-butyl-dimethyl-silanyloxy)-7a-methyl-octahydro-inden-1-yl]-propyl ester(100928-04-9)
• EPA Substance Registry System: Toluene-4-sulfonic acid2-[4-(tert-butyl-dimethyl-silanyloxy)-7a-methyl-octahydro-inden-1-yl]-propyl ester(100928-04-9)

Safety Data

• Hazardous Substances Data: 100928-04-9(Hazardous Substances Data)

Usage

General Description

Toluene-4-sulfonic acid 2-[4-(tert-butyl-dimethyl-silanyloxy)-7a-methyl-octahydro-inden-1-yl]-propyl ester is a complex chemical compound with a molecular structure containing toluene, sulfonic acid, propyl ester, and a tert-butyl-dimethyl-silanyloxy group. Toluene-4-sulfonic acid2-[4-(tert-butyl-dimethyl-silanyloxy)-7a-methyl-octahydro-inden-1-yl]-propyl ester is used in the production of various products such as pharmaceuticals, plastics, coatings, and adhesives. It is also used as a reagent in organic synthesis and as a catalyst in various chemical reactions. Toluene-4-sulfonic acid 2-[4-(tert-butyl-dimethyl-silanyloxy)-7a-methyl-octahydro-inden-1-yl]-propyl ester has a wide range of industrial applications due to its versatile chemical properties.

InChI:InChI=1/C26H44O4SSi/c1-19-11-13-21(14-12-19)31(27,28)29-18-20(2)22-15-16-23-24(10-9-17-26(22,23)6)30-32(7,8)25(3,4)5/h11-14,20,22-24H,9-10,15-18H2,1-8H3/t20-,22?,23?,24+,26-/m1/s1

Upstream product

• 66774-80-9 (S)-2-((3R,3aR,7S,7aR)-octahydro-7-hydroxy-3a-methyl-1H-inden-3-yl)propyl 4-methylbenzenesulfonate 
• 69739-34-0 t-butyldimethylsiyl triflate 
• 64190-52-9 (8S,20S)-de-A,B-20-(hydroxymethyl)pregnan-8-ol 
• 98-59-9 p-toluenesulfonyl chloride 
• 100928-00-5 3β-O-(triisopropylsilyl)-7,8-dihydroxy-7,8-dihydrovitamin D2 
• 84985-78-4 (4R,7aR)-1-((2R,5R,E)-5,6-dimethylhept-3-en-2-yl)-4-((R,Z)-1-hydroxy-2-((S)-5-hydroxy-2-methylenecyclohexylidene)ethyl)-7a-methyloctahydro-1H-inden-4-ol 
• 18162-48-6 tert-butyldimethylsilyl chloride 
• 55812-82-3 (1R,3aR,4S,7aR)-7a-methyl-1-<(2E)-(1R,4R)-1,4,5-trimethyl-hex-2-enyl>-octahydro-1H-inden-4-ol 
• 50-14-6 Calciferol 
• 100928-03-8 (S)-2-((1R,3aR,4S,7aR)-4-(tert-butyldimethylsilyloxy)-7a-methyloctahydro-1H-inden-1-yl)propan-1-ol 

Downstream Products

• 183506-75-4 (R)-2-((1R,3aR,4S,7aR)-4-(tert-butyldimethylsilyloxy)-7a-methyloctahyrdo-1H-inden-1-yl)propyl 4-methylbenzenesulfonate 
• 214351-86-7 (1R,4S,7aR)-4-(tert-butyldimethylsilyloxy)octahydro-1-((R)-1-iodopropan-2-yl)-7a-methyl-1H-indene 
• 97903-37-2 24,25,26,27-tetranor-1,23-(OH)2D₃ 
• 71204-89-2 1α,3β-dihydroxy-9,10-seco-24-norchola-5,7-10(19)-trien-23-oic acid 
• 71203-48-0 methyl 1α,3β-dihydroxy-9,10-seco-24-norchola-5,7-10(19)-trien-23-oate 
• 73809-05-9 3-epi-25-hydroxyvitamin D₃ 
• 100928-11-8 25,25-(ethylenedioxy)-27-norvitamin D₃ triisopropylsilyl ether 
• 100928-12-9 (R)-4-Methylene-3-[2-[(1R,3aS,7aR)-7a-methyl-1-[(R)-1-methyl-4-(2-methyl-[1,3]dioxolan-2-yl)-butyl]-octahydro-inden-(4E)-ylidene]-eth-(Z)-ylidene]-cyclohexanol 
• 77531-55-6 25-ketovitamin D₃ 
• 147725-63-1 (8β,20R)-8-[(tert-butyldimethylsilyl)oxy]des-A,B-pregnan-20-ol 
• 147725-62-0 (20S)-De-A,B-8β-[(tert-butyldimethylsilyl)oxy]pregnan-20-ol 
• 884488-07-7 (20S)-de-A,B-25-hydroxy-22-oxacholestan-8-one 
• 219123-74-7 (2R,6R)-6-[(1R,3aR,4S,7aR)-4-(tert-Butyl-dimethyl-silanyloxy)-7a-methyl-octahydro-inden-1-yl]-3,3-difluoro-2-methyl-1-((R)-toluene-4-sulfinyl)-heptan-2-ol 
• 219123-72-5 (R)-6-[(1R,3aR,4S,7aR)-4-(tert-Butyl-dimethyl-silanyloxy)-7a-methyl-octahydro-inden-1-yl]-3,3-difluoro-1-((R)-toluene-4-sulfinyl)-heptan-2-one 

Relevant articles and documents

Synthesis and biological evaluation of calcioic acid

Herein, we describe the synthesis of calcioic acid following a recently developed synthetic strategy for calcitroic acid. Several improvements to reaction conditions were made, which resulted in higher yields. The improved workup and isolation procedures

Efficient and scalable total synthesis of calcitroic acid and its 13C-labeled derivative

Calcitroic acid, the deactivated form of the physiological active vitamin D3 metabolite calcitrol, and its 13C labeled derivative has been synthesized starting from the commercially available Inhoffen-Lythgoe diol in 11 steps with an

Synthesis and preliminary biological evaluation of 20-epi-eldecalcitol [20-epi-1α,25-dihydroxy-2β-(3-hydroxypropoxy)vitamin D3: 20-epi-ED-71]

Eldecalcitol [1α,25-dihydroxy-2β-(3-hydroxypropoxy)vitamin D3, developing code: ED-71] is an analog of active vitamin D3, 1α,25-dihydroxyvitamin D3 [1,25(OH)2D3] that possesses a hydroxypropoxy substituent at the 2β-position of 1,25(OH)2D3. Eldecalcitol has potent biological effects on bone and is now in preparation for approval as a promising medicine for the treatment of osteoporosis in Japan. To explore chemical structure-biological activity relationships between eldecalcitol and related analogs, we have already synthesized 1-epi-eldecalcitol, 3-epi-eldecalcitol, and 1,3-diepi-eldecalcitol with inherent biological interests of each targeted analog and evaluated their biological responses. It has been reported that 20-epi-1,25(OH)2D3, a diastereomer of 1,25(OH)2D3 that possesses an inverted methyl substituent at the 20-position of the side chain, shows remarkably enhanced biological activities compared to parental compound, 1,25(OH)2D3. As a continuation of our modification studies on eldecalcitol, we took great interest in 20-epi-eldecalcitol and its biological responses. In this paper, the synthesis of 20-epi-eldecalcitol by the Trost coupling reaction between the A-ring fragment and the C/D-ring fragment as well as in vitro preliminary biological evaluation of 20-epi-eldecalcitol are described. In the induction of human myeloid leukemia cell (HL-60) differentiation, inhibition of the human histiocytic lymphoma cell (U937) proliferation, and increase in osteocalcin concentration in the human osteosarcoma cell (MG-63), 20-epi-eldecalcitol showed significantly enhanced activity compared to eldecalcitol.